Clinical trial
Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation
NCT00356967 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00356967 |
|---|---|
| Title | Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking Cessation |
| Official title | An International 7-Week, Double-Blind, Placebo-Controlled, 2-Parallel Group Study to Assess the Efficacy of Dianicline 40 mg BID as an Aid to Smoking Cessation in Cigarette Smokers |
| Acronym | EURODIAN |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking |
| Intervention type | Drug |
| Interventions | dianicline |
| Enrollment | 602 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jul 27, 2006 |
| Last update posted | Dec 19, 2008 |
| Countries | Belgium, Denmark, France, Norway, Spain, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: